HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei Liu Selected Research

methylselenic acid

1/2021EGFR-IL-6 Signaling Axis Mediated the Inhibitory Effect of Methylseleninic Acid on Esophageal Squamous Cell Carcinoma.
10/2015Upregulation of KLF4 by methylseleninic acid in human esophageal squamous cell carcinoma cells: Modification of histone H3 acetylation through HAT/HDAC interplay.
9/2015Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
10/2010beta-Catenin/TCF pathway plays a vital role in selenium induced-growth inhibition and apoptosis in esophageal squamous cell carcinoma (ESCC) cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei Liu Research Topics

Disease

128Neoplasms (Cancer)
11/2022 - 10/2002
45Infections
12/2022 - 11/2004
35Hepatocellular Carcinoma (Hepatoma)
01/2022 - 10/2006
30Breast Neoplasms (Breast Cancer)
11/2021 - 10/2002
27Inflammation (Inflammations)
07/2022 - 06/2005
23Neoplasm Metastasis (Metastasis)
01/2022 - 11/2008
18Carcinogenesis
06/2021 - 06/2005
14Fibrosis (Cirrhosis)
07/2022 - 06/2003
12Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 03/2007
11Lung Neoplasms (Lung Cancer)
12/2020 - 01/2005
11Glioma (Gliomas)
10/2019 - 10/2002
10Hypoxia (Hypoxemia)
11/2022 - 10/2002
10Parkinson Disease (Parkinson's Disease)
07/2018 - 03/2006
9Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 06/2014
9Esophageal Squamous Cell Carcinoma
01/2021 - 10/2010
9Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 05/2009
9Carcinoma (Carcinomatosis)
10/2020 - 10/2002
9Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2020 - 05/2009
8Triple Negative Breast Neoplasms
01/2022 - 12/2011
8Rheumatoid Arthritis
10/2021 - 04/2009
8Liver Diseases (Liver Disease)
01/2021 - 04/2012
7Multiple Sclerosis
02/2019 - 05/2009
7Chronic Hepatitis C
12/2018 - 01/2014
6Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 03/2009
6Atrophy
11/2015 - 01/2006
5Chronic Hepatitis B
01/2022 - 03/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2005
5Hemorrhage
10/2021 - 01/2014
5Communicable Diseases (Infectious Diseases)
10/2021 - 07/2008
5Body Weight (Weight, Body)
08/2021 - 07/2006
5Sepsis (Septicemia)
05/2021 - 02/2011
5Experimental Arthritis
01/2021 - 04/2009
5Chronic Hepatitis (Chronic Active Hepatitis)
01/2021 - 01/2014
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2018 - 09/2009
5Drug-Related Side Effects and Adverse Reactions
01/2017 - 06/2012
5Parkinsonian Disorders (Parkinsonism)
01/2017 - 02/2008
5Muscular Atrophy (Muscle Atrophy)
11/2015 - 01/2006
4COVID-19
12/2022 - 01/2020
4Adenocarcinoma
06/2022 - 02/2002
4Osteolysis
03/2022 - 11/2018
4Necrosis
01/2022 - 01/2008
4Reperfusion Injury
12/2021 - 08/2012
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 01/2018
4Psoriatic Arthritis
01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

63Proteins (Proteins, Gene)FDA Link
12/2022 - 03/2005
37Biomarkers (Surrogate Marker)IBA
11/2022 - 08/2006
29Pharmaceutical PreparationsIBA
01/2022 - 11/2008
16AntigensIBA
12/2018 - 11/2008
15MicroRNAs (MicroRNA)IBA
07/2021 - 06/2010
15Biological ProductsIBA
01/2021 - 03/2005
14CytokinesIBA
11/2021 - 02/2007
13Messenger RNA (mRNA)IBA
09/2021 - 01/2006
12Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 04/2015
11Therapeutic UsesIBA
04/2022 - 09/2003
11AutoantibodiesIBA
01/2021 - 01/2013
10VaccinesIBA
12/2022 - 07/2008
10DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2004
10RNA (Ribonucleic Acid)IBA
01/2022 - 09/2013
10LipopolysaccharidesIBA
11/2021 - 03/2007
10EnzymesIBA
01/2021 - 02/2002
8AntibodiesIBA
04/2022 - 10/2011
8Phosphotransferases (Kinase)IBA
02/2020 - 01/2010
8LigandsIBA
01/2020 - 10/2002
7ChemokinesIBA
01/2020 - 10/2015
6ErbB Receptors (EGF Receptor)IBA
01/2022 - 11/2016
6Interleukin-6 (Interleukin 6)IBA
05/2021 - 06/2015
6Long Noncoding RNAIBA
01/2021 - 12/2018
6Phenobarbital (Luminal)FDA Link
10/2020 - 09/2013
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 12/2008
6SphingolipidsIBA
01/2020 - 01/2014
6InterferonsIBA
12/2018 - 06/2012
6SurvivinIBA
01/2018 - 05/2009
5Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2014
5Chloride Channels (Chloride Channel)IBA
11/2021 - 12/2012
5Interleukin-10 (Interleukin 10)IBA
05/2021 - 06/2007
5Blood Glucose (Blood Sugar)IBA
01/2021 - 08/2010
5Indicators and Reagents (Reagents)IBA
01/2021 - 03/2013
5Mitogen-Activated Protein KinasesIBA
01/2019 - 01/2010
5TaurineFDA Link
01/2019 - 08/2010
5Pioglitazone (Actos)FDA Link
01/2017 - 03/2007
4Circular RNAIBA
01/2022 - 01/2019
4Cisplatin (Platino)FDA LinkGeneric
01/2022 - 11/2010
4Complement System Proteins (Complement)IBA
01/2022 - 11/2012
4CreatinineIBA
01/2022 - 04/2012
4Anoctamin-1IBA
11/2021 - 01/2019
4Antiviral Agents (Antivirals)IBA
07/2021 - 10/2011
4Dopamine (Intropin)FDA LinkGeneric
05/2021 - 03/2007
4Docetaxel (Taxotere)FDA Link
01/2021 - 12/2011
4AcidsIBA
01/2021 - 01/2013
4Neuroprotective AgentsIBA
01/2021 - 12/2008
4SeleniumIBA
01/2021 - 10/2010
4methylselenic acidIBA
01/2021 - 10/2010
4TriterpenesIBA
01/2021 - 06/2008

Therapy/Procedure

64Therapeutics
03/2022 - 08/2005
14Drug Therapy (Chemotherapy)
01/2022 - 03/2005
8Neoadjuvant Therapy
01/2018 - 12/2011
7Immunotherapy
01/2022 - 01/2013
6Denervation
11/2015 - 01/2006
5Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2021 - 03/2005
5Radiotherapy
01/2018 - 12/2011